Coreline Soft Secures 13th FDA Clearance with AI-Powered Aortic Measurement Software
South Korean medical AI company Coreline Soft has received U.S. Food and Drug Administration (FDA) 510(k) clearance for AVIEW Aorta Metrics, an AI-powered solution that automatically analyzes and measures the aorta using chest CT images.The clearance, granted on October 16, brings Coreline Soft's cumulative number of FDA 510(k) clearances to 13, strengthening its regulatory portfolio in the…
Coreline Soft, a South Korean medical AI company, has secured its 13th FDA 510(k) clearance for AVIEW Aorta Metrics, an AI-powered software that automatically analyzes and measures the aorta using chest CT images. This achievement expands Coreline Soft's regulatory portfolio in the United States and enhances its medical imaging capabilities in cardiovascular analysis.
The software provides standardized measurements to support clinicians in evaluating aortic dimensions and offers additional features such as straightened curved planar reconstruction, cross-sectional and three-dimensional images, and quantitative reports. By focusing on identifying anatomical segments and measuring aortic dimensions consistently, AVIEW Aorta Metrics complements existing chest CT scans and supports opportunistic analysis, allowing clinicians to extract additional quantitative information from examinations already performed.
Brief written by urgent.news from Korea IT Times's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
